
Two-pronged immune response offers hope for effective Salmonella vaccine
Research from Malawi, Birmingham and Liverpool has renewed hope that an effective vaccine could be developed against nontyphoidal strains of Salmonella.






3-5 years
Up to £3 million


Up to 8 years, spanning two phases: a foundation phase for the first 18 months, followed by a scale-up phase up to a maximum of 6.5 additional years.
Foundation phase: up to £500k; Scale-up phase: you should ask for the resources you need for your programme – see the 'What we offer' section on this page. You will need to justify this in your application.

Up to 3 years
Up to £5 million






Between 3 to 5 years
Up to £5 million per award

Up to 5 years
Between £500,000 and £2 million
Not aligned to our strategic programmes

Up to 5 years
Up to £4 million


Up to 24 months
Up to £200,000 per award

Up to 3 years
Up to £2.5 million. In exceptional cases we may award above this.